STAR — Strides Pharma Science Share News
0.000.00%
Last trade - 00:00- IN₹93.54bn
- IN₹107.43bn
- IN₹48.59bn
India's Strides Pharma rises on USFDA nod for Gabapentin tablets
Brief: Strides Pharma Science Gets US FDA Approval For Gabapentin Tablets Usp, 600 Mg And 800 Mg
India's Strides Pharma gains on posting Q3 profit
Brief: Strides Pharma Science Dec-Qtr Consol Net Profit 496.7 Mln Rupees
Brief: Strides Pharma Science Unit To Divest 100% Stake In Eris Pharma GmbH, Germany
Brief: Strides Pharma Science Unit Acquires Additional Stake In Neviton Softech
Brief: Strides Pharma Science Says Unit Availed Credit Facility From A Division Of Investec Bank, South Africa
Brief: Strides Pharma Science Launches Icosapent Ethyl Acid Soft Gel Capsules In Partnership With Amneal
India's Strides Pharma Science up on unit getting FDA approval
Brief: Strides Pharma Science- Gets USFDA Approval For Generic Suprep Bowel Prep Kit
India's Strides Pharma Science gains on US FDA nod for seizure drug
Brief: Strides Pharma Science Got USFDA Approval For Levetiracetam Oral Solution
Brief: India's Strides Pharma Science Posts Sept-Quarter Consol Net Loss
India's Strides Pharma rises on $15 mln Singapore facility sale
Brief: Strides Pharma Science Announces Sale Of Manufacturing Facility In Singapore For Consideration Of $15 Million
Brief: Strides Pharma Science Receives USFDA Approval For Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate Tablets
India's Strides Pharma up on positive earnings outlook, US FDA approval
Brief: Strides Pharma Science Receives USFDA Approval For Icosapent Ethyl Capsules
India's Strides Pharma falls after announcing spin off of unit